Back to Search
LOUIS ROSEN, DO
DO
Physical Medicine & Rehabilitation Physician
NPI: 1366590317Individual
Specialties, Licenses & Credentials
Physical Medicine & Rehabilitation PhysicianPrimary
Physical Medicine & Rehabilitation
Code: 208100000X
20A5340(CA)
Research & Publications (20)
Fathers' rights groups: demographic correlates and impact on custody policy.
PMID 19255420·Violence Against Women·2009
8-other
New approaches to assessing and treating early-stage colon and rectal cancer: summary statement from 2007 Santa Monica Conference.
PMID 18006789·Clin Cancer Res·2007
8-other
Safety, pharmacokinetics, and efficacy of AMG 706, an oral multikinase inhibitor, in patients with advanced solid tumors.
PMID 17557949·J Clin Oncol·2007
3-trial
Palifermin reduces the incidence of oral mucositis in patients with metastatic colorectal cancer treated with fluorouracil-based chemotherapy.
PMID 17075109·J Clin Oncol·2006
3-trial
Homing endonuclease I-CreI derivatives with novel DNA target specificities.
PMID 16971456·Nucleic Acids Res·2006
8-other
New generation of bisphosphonates: broad clinical utility in breast and prostate cancer.
PMID 15202585·Oncology (Williston Park)·2004
6-review
Long-term efficacy and safety of zoledronic acid in the treatment of skeletal metastases in patients with nonsmall cell lung carcinoma and other solid tumors: a randomized, Phase III, double-blind, placebo-controlled trial.
PMID 15197804·Cancer·2004
3-trial
Phase 1 study of TLK286 (Telcyta) administered weekly in advanced malignancies.
PMID 15173075·Clin Cancer Res·2004
3-trial
Zoledronic acid is superior to pamidronate for the treatment of bone metastases in breast carcinoma patients with at least one osteolytic lesion.
PMID 14692022·Cancer·2004
3-trial
Long-term efficacy and safety of zoledronic acid compared with pamidronate disodium in the treatment of skeletal complications in patients with advanced multiple myeloma or breast carcinoma: a randomized, double-blind, multicenter, comparative trial.
PMID 14534891·Cancer·2003
3-trial
Zoledronic acid versus placebo in the treatment of skeletal metastases in patients with lung cancer and other solid tumors: a phase III, double-blind, randomized trial--the Zoledronic Acid Lung Cancer and Other Solid Tumors Study Group.
PMID 12915606·J Clin Oncol·2003
3-trial
Phase I study of TLK286 (glutathione S-transferase P1-1 activated glutathione analogue) in advanced refractory solid malignancies.
PMID 12738715·Clin Cancer Res·2003
3-trial
Efficacy and safety of zoledronic acid in the treatment of bone metastases associated with lung cancer and other solid tumors.
PMID 12584692·Semin Oncol·2002
3-trial
Broad clinical activity of zoledronic acid in osteolytic to osteoblastic bone lesions in patients with a broad range of solid tumors.
PMID 12562047·Am J Clin Oncol·2002
6-review
Inhibitors of the vascular endothelial growth factor receptor.
PMID 12512388·Hematol Oncol Clin North Am·2002
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 4647 ZION AVE
SAN DIEGO, CA 92120 - Phone
- (619) 528-5000
Quick Facts
- NPI
- 1366590317
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile